Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Jäger

Showing results (1-10 of 323) with videos related to

Pageof 33
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Potential target antigens for immunotherapy identified by serological expression cloning (SEREX)Dirk Jäger
Oncology Research and Treatment|October 11, 2014
[Immuno-Oncology "Coming of Age" - the next generation of immune checkpoint inhibitors ]Dirk Schadendorf, Dirk Jäger
Nature Nanotechnology|December 12, 2018
Surgical wound immunotherapyReinhard Liebers, Dirk Jäger
Breast (Edinburgh, Scotland)|October 26, 2005
Antibodies and vaccines--hope or illusion?Dirk Jäger, Alexander Knuth
Gastrointestinal Cancer Research : GCR|March 5, 2009
Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancersFlorian Lordick, Dirk Jäger
International Journal of Cancer|August 15, 2003
Antigen-specific immunotherapy and cancer vaccinesElke Jäger, Dirk Jäger, Alexander Knuth
Frontiers in Immunology|November 3, 2018
HLA-E Peptide Repertoire and Dimorphism-Centerpieces in the Adaptive NK Cell Puzzle?Alexander Rölle, Dirk Jäger, Frank Momburg
Current Opinion in Immunology|March 1, 2002
Clinical cancer vaccine trialsElke Jäger, Dirk Jäger, Alexander Knuth
Frontiers in Immunology|May 9, 2012
Predictive immunological markers in oncologyDirk Jäger, Inka Seil, Niels Halama
Oncology Research and Treatment|June 10, 2025
Management of Advanced Renal Cell CarcinomaXin-Wen Zhang, Dirk Jäger, Stefanie Zschäbitz
Pageof 33

Showing results (1-10 of 323) with videos related to

Sort By:
Pageof 33
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Potential target antigens for immunotherapy identified by serological expression cloning (SEREX)Dirk Jäger
Oncology Research and Treatment|October 11, 2014
[Immuno-Oncology "Coming of Age" - the next generation of immune checkpoint inhibitors ]Dirk Schadendorf, Dirk Jäger
Nature Nanotechnology|December 12, 2018
Surgical wound immunotherapyReinhard Liebers, Dirk Jäger
Breast (Edinburgh, Scotland)|October 26, 2005
Antibodies and vaccines--hope or illusion?Dirk Jäger, Alexander Knuth
Gastrointestinal Cancer Research : GCR|March 5, 2009
Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancersFlorian Lordick, Dirk Jäger
International Journal of Cancer|August 15, 2003
Antigen-specific immunotherapy and cancer vaccinesElke Jäger, Dirk Jäger, Alexander Knuth
Frontiers in Immunology|November 3, 2018
HLA-E Peptide Repertoire and Dimorphism-Centerpieces in the Adaptive NK Cell Puzzle?Alexander Rölle, Dirk Jäger, Frank Momburg
Current Opinion in Immunology|March 1, 2002
Clinical cancer vaccine trialsElke Jäger, Dirk Jäger, Alexander Knuth
Frontiers in Immunology|May 9, 2012
Predictive immunological markers in oncologyDirk Jäger, Inka Seil, Niels Halama
Oncology Research and Treatment|June 10, 2025
Management of Advanced Renal Cell CarcinomaXin-Wen Zhang, Dirk Jäger, Stefanie Zschäbitz
Pageof 33